# Genotypic Resistance Guided Therapy in Helicobacter Pylori Eradication

> **NCT01725906** · PHASE4 · UNKNOWN · sponsor: **National Taiwan University Hospital** · enrollment: 450 (estimated)

## Conditions studied

- Self Efficacy

## Interventions

- **DRUG:** empirical therapy
- **DRUG:** Genotypic resistance guided therapy

## Key facts

- **NCT ID:** NCT01725906
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-11
- **Primary completion:** 2017-05
- **Final completion:** 2017-12
- **Target enrollment:** 450 (ESTIMATED)
- **Last updated:** 2017-05-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01725906

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01725906, "Genotypic Resistance Guided Therapy in Helicobacter Pylori Eradication". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01725906. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*